Consolidated Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Cash flows from operating activities:
Net (loss) income	$ 835,419	$ (3,498,152)	$ (5,401,961)	$ (5,798,578)	$ (7,588,845)	$ (18,510,882)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization					68,255	22,527
Imputed interest					4,185	15,920
Interest expense - amortization of debt discounts					2,285,817	4,293,367
Additional non-cash interest expense due to debt restructuring					620,160
Stock compensation expense					460,037	5,514,675
Loss in extinguishment of debt - related party						297,138
Change in fair value of derivative liability					974,446	(336,140)
Gain or loss in debt settlement					(813,378)
Loss in extinguishment of debt					1,190,809	148,509
Accretion expense - excess derivative liability					758,265	675,388
Impairment of intangibles assets
Net changes in operating assets & liabilities:
Accounts receivable					(545,354)	173,257
Inventory
Other receivable
Prepaid expense, deposits and other current assets					445,954	(227,693)
Other assets
Accounts payable, accrued liabilities, due to affiliates, and other long-term liabilities					296,583	780,022
Net cash used in operating activities					(1,843,066)	(7,153,911)
Cash flows from investing activities:
Purchases of property, plant, and equipment					(5,000)	(33,900)
Purchases of intangible assets					(293,877)	(268,916)
Cash received from acquisition of Magiclytics						76
Net cash used in investing activities					(298,877)	(302,740)
Cash flows from financing activities:
Shares issued for cash					596,258	845,290
Borrowing from related party note payable					525,050	244,803
Repayment to related party convertible note payable					(105,822)	(137,500)
Borrowings from convertible notes payable					888,062	7,712,445
Repayment to convertible notes payable					(18,119)	(455,000)
Net cash provided by financing activities					1,885,429	8,210,038
Net increase in cash and cash equivalents					(256,514)	753,387
Cash and cash equivalents at beginning of period		$ 299,520		$ 37,774	299,520	37,774	$ 37,774
Cash and cash equivalents at end of period	$ 43,006		$ 791,161		43,006	791,161	$ 299,520
Cash paid during the period for:
Interest
Income taxes
Supplemental disclosure of non-cash investing and financing Activities:
Shares issued for conversion from convertible note payable					2,945,019	1,313,530
Shares issued to settle accounts payable						397,992
Reclass of derivative liability to additional paid in capital					$ 2,134,128